Skip to content

Consequences of a congenital monokidney in patients with MCKD

Consequences of a congenital monokidney in patients with MCKD - ConscmkMCKD

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33413
Enrollment
122
Registered
2010-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MCKD

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: MCKD; Nephrectomy;

Exclusion criteria

Exclusion criteria: Heminephrectomy Conservatively managed Congenital abnormality contralateral kidney

Design outcomes

Primary

MeasureTime frame
Previous medical history: parity of mother at birth, gestational age at birth, birth weight, birth length, singleton / multiple pregnancy, urinal and faecal continence, infection of urinary tract, obstipation Family history: diabetes (type), cardiovascular disease, hypertension, kidney disease / renal anomalies History: medication, smoking, alcoholintake Physical examination: height, weight, BMI, waist circumference (waist/hip ratio), blood pressure (measured three times in seating position with a Dinamap oscillometer)

Secondary

MeasureTime frame
Kidney ultrasound: kidneysize (compared to normal deviation), thickness of parenchyma, transverse dimension and if possible kidney length. Blood sampling: Cystatin-C, NGAL (neutrophil gelatinase-associated lipocalin), creatinine, uric acid, urea, HbA1C, glucose, Calcium and Phosphate Urinary sampling: TGF-beta1, sediment, screening, albumin/creatinine ratio and protein.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)